Raymond Demotte - South American Director
| SAGD Stock | USD 0.0001 0.00 0.00% |
Director
Mr. Raymond DeMotte is President Vice President Corporationrationrate Development and Operations Controller Director of South American Gold Corporationration Mr. DeMotte served as Vice President of Business Development and as a director of Boulder Hill Mines Inc. a private mineral exploration company based in Idaho since June 2008 through December 2011. Mr. DeMotte served as President and CEO of Sterling Mining Company from November 1998 to May 2008 and served as a director of Sterling Mining Company from November 2008 to February 2009. Earlier in his career Mr. De Motte worked for Bechtel and Mckesson. Mr. DeMotte is a director and serves on the audit committee for Silverfield Resources Inc. and Wescan Uranium Inc. Mr. DeMotte holds a BS in International Business Administration from the American College of Switzerland and a MBA in International Management from Golden Gate University in San Francisco California. Mr. DeMotte is a member of the Canadian Institute of Mining Metallurgy and Petroleum the American Historical Association the American Philological Association the Society of Mining Engineers . since 2014.
| Age | 66 |
| Tenure | 10 years |
| Phone | 702-850-3386 |
| Web | https://www.sativagrowth.com |
South American Management Efficiency
The company has return on total asset (ROA) of (14.4448) % which means that it has lost $14.4448 on every $100 spent on assets. This is way below average. South American's management efficiency ratios could be used to measure how well South American manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Patrick Heron | Collegium Pharmaceutical | 44 | |
| John Byom | Prestige Brand Holdings | 66 | |
| Christopher Nash | HUTCHMED DRC | 56 | |
| Donald Morel | Catalent | 63 | |
| Karen Ferrante | HUTCHMED DRC | 58 | |
| BSE CS | HUTCHMED DRC | 72 | |
| Joseph Nitzani | Teva Pharma Industries | 70 | |
| Theodore Schroeder | Collegium Pharmaceutical | 63 | |
| Gerald Lieberman | Teva Pharma Industries | 73 | |
| Edward Owens | Ironwood Pharmaceuticals | 71 | |
| Takayoshi Ikeda | HUTCHMED DRC | N/A | |
| John Greisch | Catalent | 65 | |
| Nicole Vitullo | Esperion Therapeutics | 60 | |
| Dennis Walsh | Deciphera Pharmaceuticals LLC | 50 | |
| C Wasser | Takeda Pharmaceutical Co | N/A | |
| Nechemia Peres | Teva Pharma Industries | 61 | |
| Madhavan Balachandran | Catalent | 69 | |
| Sheila Hopkins | Prestige Brand Holdings | 64 | |
| Heather Mason | Assertio Therapeutics | 64 | |
| Antonio Gotto | Esperion Therapeutics | 83 | |
| Willie Reed | Zoetis Inc | 65 | |
Management Performance
| Return On Asset | -14.44 |
South American Gold Leadership Team
Elected by the shareholders, the South American's board of directors comprises two types of representatives: South American inside directors who are chosen from within the company, and outside directors, selected externally and held independent of South. The board's role is to monitor South American's management team and ensure that shareholders' interests are well served. South American's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, South American's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Quinn Bastian, Independent Director | ||
| Joseph Hanks, CFO VP | ||
| David Kugelman, CEO and Director | ||
| David Reeves, President | ||
| Raymond Demotte, VP of Corporate Devel., Operations Controller, Director, Member of Audit Committee and Member of Compensation Committee | ||
| Rene Boeck, VP of Exploration | ||
| Ed Jang, Director | ||
| Christian Gomez, CFO, Treasurer and Secretary | ||
| Francis Delzer, VP of Operations, Director, Member of Compensation Committee and Member of Audit Committee | ||
| Edwin Jang, Ex Director |
South Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is South American a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -14.44 | |||
| Current Valuation | 69.04 K | |||
| Shares Outstanding | 144.53 K | |||
| Revenue | 8.19 K | |||
| EBITDA | (246.14 K) | |||
| Net Income | (124.91 K) | |||
| Cash And Equivalents | 53 | |||
| Total Debt | 64.76 K | |||
| Book Value Per Share | (3.16) X | |||
| Cash Flow From Operations | 341.06 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards South American in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, South American's short interest history, or implied volatility extrapolated from South American options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in South American Gold. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the South American Gold information on this page should be used as a complementary analysis to other South American's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for South Pink Sheet analysis
When running South American's price analysis, check to measure South American's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy South American is operating at the current time. Most of South American's value examination focuses on studying past and present price action to predict the probability of South American's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move South American's price. Additionally, you may evaluate how the addition of South American to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |